McKesson Corporation announced today the creation of a new division, McKesson Specialty Health, focused on empowering the community patient care delivery system to advance the science, technology and quality of care.
“Through innovative technology, clinical support and business solutions, McKesson Specialty Health offers the broadest and deepest suite of services available today, all focused on improving the health of community practices and the patients they serve,” said Bruce Broussard, CEO, McKesson Specialty Health. “We are thousands of committed experts who believe that the long-term vibrancy of community practices will be achieved through the leadership of physicians committed to clinical excellence and innovation. Our mission is to strengthen the community patient care delivery system through our deep clinical, operational and technological expertise.”
Less than a year ago, McKesson Corporation acquired US Oncology with a vision of enhancing its customer offerings. Through integrated technology offerings, including iKnowMed™, the top-ranked web-based oncology EHR, and the market-leading Lynx Mobile® drug inventory management system, deep clinical support expertise, one of the nation’s largest cancer research networks and unrivaled understanding of community care, McKesson Specialty Health improves the financial health of its customers while empowering them to advance the science, quality and efficiency of patient care.
“We have taken the best of McKesson Specialty Care Solutions and US Oncology to create McKesson Specialty Health, an organization that can truly help the community-based care system achieve better health,” said Mark Walchirk, president, McKesson Specialty Health. “Our customers now have even more ways to engage with us as suits their needs, better enabling them to secure their own future at the forefront of excellent, high-quality and efficient patient care.”
Enhanced solutions for providers
McKesson Specialty Health provides solutions across multiple specialties. From oncology and rheumatology to gastroenterology, nephrology, and urology, McKesson Specialty Health is committed to strengthening community practices.
Solutions for Oncology
McKesson Specialty Health Solutions for Oncology provides community oncology practices the choice, flexibility and ability to engage with and benefit from a wide variety of innovative clinical, technology and business capabilities. By engaging with McKesson Specialty Health’s Solutions for Oncology through either the expanded Onmark Select Program or The US Oncology Network, providers are empowered to advance the science and delivery of patient care in the way that best suits the needs of each individual practice.
Pharmaceutical & Biotech Solutions
McKesson Specialty Health provides Pharmaceutical & Biotech Solutions for bio-pharmaceutical manufacturers including a suite of services to accelerate the development and successful commercialization of specialty pharmaceuticals across the product life cycle to speed patient access to breakthrough therapies.